Virpax selects Altasciences to develop a drug to prevent the spread of flu like viruses

Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
​​
-
MedNews on financings, strategic relationships, products, services and technology, including launches
​
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
​
.jpg)
Pharma, Biopharma & Biotech News




- Sep 15
Aclipse Therapeutics Expands Drug Development Pipeline for Gastroparesis

- Sep 13
Zevra Therapeutics Presents Full Data Set on the Cardiovascular Safety and Pharmacokinetics of SDX


- Sep 12
Shine Technologies and Curadh MTR Expand Partnership for Cancer Therapies using Terbium and Lutetium


- Aug 28
Inhibikase Therapeutics develops novel formulation of risvodetinib


- Aug 25
Botanical Solution raises an additional $7 Million to scale up production of vaccine adjuvants


- Aug 18
Novo Holdings participates in $290 million strategic financing of Sangon Biotech


- Aug 7
AI-driven pioneer in drug formulation, Persist AI, raises $4 million


- Aug 4
Adamis Pharmaceuticals prices $8 million public offering

- Jul 24
PainReform, a clinical-stage specialty pharmaceutical company prices $2.7 million financing

- Jul 19
Clinical stage biopharmaceutical company Galmed Pharmaceuticals prices $7 million public offering


- Jun 26
Tagworks Pharmaceuticals closes a $65 Million financing to advance its Click-to-Release therapeutics


- Jun 21
Turbine, which uses cell simulations increases its current financing to €25.5 million


- Jun 19
RK Pharma wraps up acquisition of developer of clinical critical therapies VGYAAN Pharmaceuticals


- Jun 13
HanAll Biopharma and Daewoong Pharmaceutical invest in Vincere Biosciences for Parkinson's Research

- Jun 7
CERo Therapeutics to merge with SPAC and advance engineered T Cell therapeutics


- Jun 2
Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure


- May 26
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons


- May 19
Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics


- May 12
Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction


- May 11
Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology


- May 6
MultiOmic Health Closes $6.2 Million for precision medicines for metabolic syndrome conditions


- May 5
Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities

- May 3
Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials


- Apr 25
ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP


- Apr 18
Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

- Apr 14
Novo Holdings participates in $105 million funding in Alentis Therapeutics

- Apr 3
Orion is building a pharmaceutical research ecosystem using data and artificial intelligence


- Mar 30
Viking Therapeutics prices $250 Million public common stock offering

- Mar 28
EpiBiologics raises $50 million for next-generation antibody-based protein degradation platform


- Mar 4
Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer


- Mar 2
Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

- Feb 24
Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million


- Feb 22
Rare and orphan disease focused Quoin Pharmaceuticals (Nasdaq: QNRX) prices $7 million placement

- Feb 17
LifeArc Ventures participates in a $16 million financing for Maxion Therapeutics for antibody drugs

- Feb 15
Great Product Ventures initiates strategic relationship with life sciences regulatory services firm


- Feb 14
Nasdaq-listed SeqLL prices $1.8 million offering


- Feb 13
Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms


- Feb 1
Panbela prices $15 million public offering


- Jan 18
To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab


- Jan 10
Trinity Biotech partners with imaware to deliver diagnostic testing solutions for digital health

- Jan 7
Retinal Degeneration Fund participates in a $78 million funding round for Perceive Biotherapeutics


- Jan 4
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea


- Jan 3
Biocytogen and Hansoh Pharma Enter Into An Antibody License Agreement

- Dec 27, 2022
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies


- Dec 11, 2022
iBio, an AI-driven innovator of precision antibody immunotherapies, closes $3.5 million financing


- Dec 9, 2022
OMNY Health Closes $17 Million to Lead the Next Generation of Real-World Data-Driven Decision-Making


- Nov 29, 2022
MIT: New CRISPR-based tool inserts large DNA sequences at desired sites in cells


- Nov 23, 2022
scPharmaceuticals Announces Pricing of $50 Million Public Offering


- Nov 5, 2022
H.I.G. Capital acquires leading global clinical research organization Celerion
